Tuesday March 21, 11:15am-12:30pm PT While traditional research funding methods are still the predominate method used by HRA members, a growing number of members use non-traditional models. In this session we heard from funders who have developed new ways to address gaps and needs in the research funding landscape, and explore the innovative new programs they have designed along with lessons learned in implementation. Moderator Lara Bethke, PhD Chief Science Officer | Health Resources in Action Lara Bethke is the chief scientific officer at Health Resources in Action. Drawing on over 25 years of experience in life science research, consulting,... read more →
New Search
If you are not happy with the results below please do another searchThe Flinn Foundation launched the bioscience Entrepreneurship Program in 2014 to foster entrepreneurship and help bioscience founders/CEOs develop their early-stage companies into successful and sustainable businesses bringing new therapies, medical devices, and medical technologies to the market . 8 years on, with over 40 investments in companies such as GT Medical, developer of the GammeTile, a new treatment for people with brain tumors and Iron Horse Diagnostics, the developer of a diagnostic for the early detection of ALS/Lou Gehrig's disease what have we learned? The presentation will discuss the program design and outcomes, and the goal to build a similar... read more →
Recent events have forced member organizations to examine the gaps in the current biomedical research system - exposing areas of weakness, while also highlighting areas of immense opportunity. This ‘open mic’ session will explore innovative concepts and actions have the potential to revolutionize all aspects of the work of funders in the next decade (and beyond). The experiences gained during this challenging period in history have motivated many organizations to rethink how they serve their communities – from opting for faster, more efficient, and more open dissemination of research results, to accelerating the awarding of research grants, to equitably support... read more →
JLABS is a part of Johnson & Johnson Innovation. It is a life science incubator with an aim towards developing healthcare products from current scientific discoveries through a “capital-efficient, resource-rich environment.”
ASAPbio, Howard Hughes Medical Institute, and the Wellcome Trust held a meeting to discuss the merits of transparent peer review. If it is desirable, how can it be implemented and what might be barriers to adoption? The agenda and links to the slides and talks can be found on the ASAPBio site. Recommendations included a move to a system where peer review reports are attached to the article and for funders to acknowledge applicants and grantees peer review as scholarly contributions to science.
Most HRA members fund grants through competitive applications processes. We must sort through the proposals and make decisions on how best to spend our available dollars to achieve the strategic goals of our organization. Most of us use some variation on the process of peer reviews to rank the meritorious proposals selected by the committee into a fundable slate. Some also use an additional interview process after peer review by the committee to finalize the application for funding support, or site-visit, which in recent years may be by video-conference. However, many people are concerned that the review processes do not... read more →
Here are some recent articles about Artificial Intelligence and Large Language Models that may be of interest to the HRA community: SUPPORTING RESEARCH ChatGPT and generative AI: 25 applications to support research (October 2023; Final installation of the Times Higher Education series looking at 100 ways to use ChatGPT in higher education, which includes assistance with grant writing and generating research ideas.) Science and the new age of AI (November 2023; Collection of articles from Nature examines “looks at how [growth of AI and its capabilities] are affecting different areas of science — and how it should respond to the... read more →
Tuesday October 17, 12:45pm-1:45pm CT This session discussed the use of alternative measures to track success in evaluating and highlighting the impact of grant funding – both during the grant term and post award. During this session we learned strategies for collecting data from grantees and alumni to tracking research progress, and professional transitions. HRA member organizations shared measures they use to track success and how they collect that data. Moderator Jennifer Chang, PhD Science Manager | American Brain Tumor Foundation Presenters Bruce Weinberg, PhD Eric Byron Fix-Monda Endowed Professor | The Ohio State University Department of Economics Bruce A.... read more →
Tuesday October 17, 2:00pm-3:45pm CT This session will discuss how biomedical research funding trends and priorities have evolved and continue to adapt. This session will discuss how the rising costs of research impacts what funders are doing, how funders have changed who they are funding in terms of career stage, and how funders have changed what types of science they are funding. To give a broad perspective, this session will include the perspective of philanthropic organizations and venture capitalism. Moderator Kevin Sia, PhD Program Officer for Medical Research | Doris Duke Foundation Presenters Cara Altimus, PhD Senior Director | Milken... read more →
Monday October 16, 1:30pm-2:45pm CT How can funders move more of their funded research towards clinical relevance? This session explored specific things philanthropic funders can do to increase the likelihood of improving patient outcomes. It included a contextual update on how the research, regulatory, and commercial landscapes are changing, and how this might shift the highest impact funding opportunities for foundations. It focused on how funders can help drive research findings into clinical practice, including strategies to empower stakeholders throughout the pipeline to work across cultural and professional boundaries. Relevant resources shared by Chris Austin after the session: National Center... read more →